Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dr Mohsin Badat, a Clinical Training Research Fellow from the Higgs and Davies Groups has been awarded the ASH-BSH Abstract Achievement Award by the American Society of Haematology and the British Society of Haematology.

Headshot of Dr Mohsin Badat. © Created on Canva Pro Account

The award recognises the abstract titled ‘Base Editing Repairs the HbE Mutation Restoring the Production of Normal Globin Chains in Severe HbE/β-Thalassemia Patient Hematopoietic Stem Cells and Erythroid Cells’ which was submitted to the 63rd ASH Annual Meeting and Exposition.

The ASH-BSH Abstract Achievement Award is an annual award celebrating trainees with the highest scoring abstracts at the meeting, of which they are first or senior author.

'I'm very grateful to the American Society of Hematology and the British Society for Haematology for this generous joint award.' says Dr Badat. 'The stipend will allow me to travel to the American Society of Hematology's annual meeting this year in Atlanta, where I will have the opportunity to present our recent progress in developing a base editing cure for HbE/beta-thalassaemia to the wider international haematology community. I hope that through this we will be able to collaborate with others in the field to help bring our approach into the clinical arena.'

Dr Badat will present during the Oral and Poster Abstracts session taking place on the evening of Sunday the 12th December 2021. 

Many Congratulations to Dr Badat!

Recent stories

New technology helps decode the genetic changes behind disease

Researchers from the Milne, Hughes and Davies Groups have developed a new technology that can reveal new therapeutic targets from common genetic variants linked to disease.

Everyday DNA damage reveals a hidden weakness in some cancers

Researchers in the Chapman Group have discovered why cancer cells lacking a protein called ATM are particularly vulnerable to a class of cancer drugs known as PARP inhibitors, solving a scientific puzzle that has challenged researchers for nearly 20 years.

Professor Marella de Bruijn receives MRC Programme Award

Congratulations to Professor de Bruijn, who has been awarded funding from the UKRI Medical Research Council to investigate how the first blood stem cells formed in the embryo acquire their exceptional regenerative potential, with the aim of informing future stem cell therapies.

Professor Bethan Psaila wins ISEH Janet Rowley Award

Congratulations to Professor Psaila, who has received the 2026 Janet Rowley Award from the International Society for Experimental Hematology, in recognition of her outstanding contributions in the field of experimental haematology.

Professor KJ Patel awarded Royal Society Buchanan Medal

Congratulations to Professor Patel, who has received the Buchanan Medal, which recognises distinguished contributions to the biomedical sciences.

A summer of science and engagement

This summer, researchers at the MRC WIMM have taken part in a variety of public engagement activities, leading a stand at Cheltenham Science Festival and welcoming students for the Institute's summer work experience programme.